• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

浆细胞样树突状细胞与髓样树突状细胞协同作用,诱导抗原特异性抗肿瘤免疫反应。

Plasmacytoid dendritic cells synergize with myeloid dendritic cells in the induction of antigen-specific antitumor immune responses.

作者信息

Lou Yanyan, Liu Chengwen, Kim Grace J, Liu Yong-Jun, Hwu Patrick, Wang Gang

机构信息

Department of Melanoma Medical Oncology, Center for Cancer Immunology Research, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.

出版信息

J Immunol. 2007 Feb 1;178(3):1534-41. doi: 10.4049/jimmunol.178.3.1534.

DOI:10.4049/jimmunol.178.3.1534
PMID:17237402
Abstract

Plasmacytoid dendritic cells (pDC) are capable of producing high levels of type I IFNs upon viral stimulation, and play a central role in modulating innate and adaptive immunity against viral infections. Whereas many studies have assessed myeloid dendritic cells (mDC) in the induction of antitumor immune responses, the role of pDC in antitumor immunity has not been addressed. Moreover, the interaction of pDC with other dendritic cell subsets has not been evaluated. In this study, we analyzed the capacity of pDC in stimulating an Ag-specific T cell response. Immunization of mice with Ag-pulsed, activated pDC significantly augmented Ag-specific CD8(+) CTL responses, and protected mice from a subsequent tumor challenge. Immunization with a mixture of activated pDC plus mDC resulted in increased levels of Ag-specific CD8(+) T cells and an enhanced antitumor response compared with immunization with either dendritic cell subset alone. Synergy between pDC and mDC in their ability to activate T cells was dependent on MHC I expression by mDC, but not pDC, suggesting that pDC enhanced the ability of mDC to present Ag to T cells. Our results demonstrate that pDC and mDC can interact synergistically to induce an Ag-specific antitumor immune response in vivo.

摘要

浆细胞样树突状细胞(pDC)在病毒刺激下能够产生高水平的I型干扰素,并在调节针对病毒感染的固有免疫和适应性免疫中发挥核心作用。尽管许多研究评估了髓样树突状细胞(mDC)在诱导抗肿瘤免疫反应中的作用,但pDC在抗肿瘤免疫中的作用尚未得到探讨。此外,pDC与其他树突状细胞亚群的相互作用也未得到评估。在本研究中,我们分析了pDC刺激抗原特异性T细胞反应的能力。用抗原脉冲激活的pDC免疫小鼠可显著增强抗原特异性CD8(+) CTL反应,并保护小鼠免受随后的肿瘤攻击。与单独用任一树突状细胞亚群免疫相比,用激活的pDC加mDC的混合物免疫可导致抗原特异性CD8(+) T细胞水平升高和抗肿瘤反应增强。pDC和mDC激活T细胞能力的协同作用取决于mDC而非pDC的MHC I表达,这表明pDC增强了mDC向T细胞呈递抗原的能力。我们的结果表明,pDC和mDC可协同相互作用以在体内诱导抗原特异性抗肿瘤免疫反应。

相似文献

1
Plasmacytoid dendritic cells synergize with myeloid dendritic cells in the induction of antigen-specific antitumor immune responses.浆细胞样树突状细胞与髓样树突状细胞协同作用,诱导抗原特异性抗肿瘤免疫反应。
J Immunol. 2007 Feb 1;178(3):1534-41. doi: 10.4049/jimmunol.178.3.1534.
2
Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens.用编码内源性肿瘤相关抗原的腺病毒载体转导的树突状细胞诱导抗肿瘤免疫。
J Immunol. 1999 Jul 15;163(2):699-707.
3
Tumor-specific Tc1, but not Tc2, cells deliver protective antitumor immunity.肿瘤特异性Tc1细胞而非Tc2细胞可提供保护性抗肿瘤免疫。
J Immunol. 2001 Dec 1;167(11):6497-502. doi: 10.4049/jimmunol.167.11.6497.
4
CD8+ T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity.体内CD8 + T细胞依赖性清除树突状细胞会限制抗肿瘤免疫的诱导。
J Immunol. 2000 Mar 15;164(6):3095-101. doi: 10.4049/jimmunol.164.6.3095.
5
[Anti-lung cancer effect of myeloid and plasmacytoid dendritic cell combined vaccines loaded with tumor cell lysates in vitro].[负载肿瘤细胞裂解物的髓样和浆细胞样树突状细胞联合疫苗体外抗肺癌作用]
Zhonghua Zhong Liu Za Zhi. 2019 Jul 23;41(7):501-507. doi: 10.3760/cma.j.issn.0253-3766.2019.07.004.
6
Activation of dendritic cells that cross-present tumor-derived antigen licenses CD8+ CTL to cause tumor eradication.交叉呈递肿瘤衍生抗原的树突状细胞的激活使CD8 + 细胞毒性T淋巴细胞能够根除肿瘤。
J Immunol. 2004 Dec 1;173(11):6753-9. doi: 10.4049/jimmunol.173.11.6753.
7
Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.在一种新型的、转人癌胚抗原和HLA - A2基因的小鼠模型中,采用抗独特型疫苗和癌胚抗原CTL肽联合治疗已形成的肿瘤。
Cancer Res. 2007 Mar 15;67(6):2881-92. doi: 10.1158/0008-5472.CAN-06-3045.
8
Myeloid and plasmacytoid dendritic cell combined vaccines loaded with heat-treated tumor cell lysates enhance antitumor activity in murine lung cancer.负载经热处理的肿瘤细胞裂解物的髓样和浆细胞样树突状细胞联合疫苗增强小鼠肺癌的抗肿瘤活性。
Oncol Lett. 2021 Feb;21(2):90. doi: 10.3892/ol.2020.12351. Epub 2020 Dec 6.
9
Subversion of plasmacytoid and myeloid dendritic cell functions in chronic HCV infection.慢性丙型肝炎病毒感染中浆细胞样和髓样树突状细胞功能的颠覆。
Immunobiology. 2005;210(2-4):237-47. doi: 10.1016/j.imbio.2005.05.018.
10
Natural killer cells play a critical role in the immune response following immunization with melanoma-antigen-engineered dendritic cells.自然杀伤细胞在接种黑色素瘤抗原工程化树突状细胞后的免疫反应中发挥关键作用。
Cancer Gene Ther. 2005 Jun;12(6):516-27. doi: 10.1038/sj.cgt.7700818.

引用本文的文献

1
A novel immunomodulating peptide with potential to complement oligodeoxynucleotide-mediated adjuvanticity in vaccination strategies.一种新型免疫调节肽,具有在疫苗接种策略中补充寡脱氧核苷酸介导的佐剂活性的潜力。
Sci Rep. 2024 Nov 5;14(1):26737. doi: 10.1038/s41598-024-78150-7.
2
Plasmacytoid dendritic cells at the forefront of anti-cancer immunity: rewiring strategies for tumor microenvironment remodeling.浆细胞样树突状细胞在抗肿瘤免疫的最前沿:重塑肿瘤微环境的重布线策略。
J Exp Clin Cancer Res. 2024 Jul 17;43(1):196. doi: 10.1186/s13046-024-03121-9.
3
Inhibitory receptors of plasmacytoid dendritic cells as possible targets for checkpoint blockade in cancer.
浆细胞样树突状细胞的抑制性受体作为癌症检查点阻断治疗的潜在靶点。
Front Immunol. 2024 Mar 5;15:1360291. doi: 10.3389/fimmu.2024.1360291. eCollection 2024.
4
Macrophage barrier in the tumor microenvironment and potential clinical applications.肿瘤微环境中的巨噬细胞屏障及其潜在临床应用
Cell Commun Signal. 2024 Jan 26;22(1):74. doi: 10.1186/s12964-023-01424-6.
5
Dendritic Cell Vaccination in Non-Small Cell Lung Cancer: Remodeling the Tumor Immune Microenvironment.非小细胞肺癌中的树突状细胞疫苗接种:重塑肿瘤免疫微环境
Cells. 2023 Oct 4;12(19):2404. doi: 10.3390/cells12192404.
6
Dendritic Cell Subsets in Melanoma: Pathophysiology, Clinical Prognosis and Therapeutic Exploitation.黑色素瘤中的树突状细胞亚群:病理生理学、临床预后及治疗应用
Cancers (Basel). 2023 Apr 8;15(8):2206. doi: 10.3390/cancers15082206.
7
Surgically Derived Cancer Cell Membrane-Coated R837-Loaded Poly(2-Oxazoline) Nanoparticles for Prostate Cancer Immunotherapy.用于前列腺癌免疫治疗的手术衍生癌细胞细胞膜包被的 R837 负载聚(2-恶唑啉)纳米粒子。
ACS Appl Mater Interfaces. 2023 Feb 15;15(6):7878-7886. doi: 10.1021/acsami.2c22363. Epub 2023 Feb 4.
8
Immunological responses to adjuvant vaccination with combined CD1c myeloid and plasmacytoid dendritic cells in stage III melanoma patients.III 期黑色素瘤患者中联合 CD1c 髓样和浆细胞样树突状细胞佐剂疫苗接种的免疫反应。
Oncoimmunology. 2021 Dec 30;11(1):2015113. doi: 10.1080/2162402X.2021.2015113. eCollection 2022.
9
Nanoparticle vaccines can be designed to induce pDC support of mDCs for increased antigen display.纳米颗粒疫苗可设计为诱导 pDC 支持 mDC 以增加抗原呈递。
Biomater Sci. 2023 Jan 17;11(2):596-610. doi: 10.1039/d2bm01132h.
10
Establishment of a lncRNA-Based Prognostic Gene Signature Associated With Altered Immune Responses in HCC.建立基于长链非编码 RNA 的与 HCC 中免疫反应改变相关的预后基因特征。
Front Immunol. 2022 Apr 28;13:880288. doi: 10.3389/fimmu.2022.880288. eCollection 2022.